Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 1

Conditions

Cardiotoxicity 2Peritoneal Neoplasms 1Neoplasms 1Heart Failure 1Breast Neoplasms 1

Interventions

Exercise 8salicylhydroxamic acid 2High-Intensity Interval Training 2Electrocardiography 2Echocardiography 2sacubitril and valsartan sodium hydrate drug combination 1mitoquinone 1epicatechin gallate 1candesartan 1Therapeutics 1Surveys and Questionnaires 1Secondary Prevention 1Restraint, Physical 1Rehabilitation 1Proton Therapy 1Proteins 1Palliative Care 1Methods 1Medical History Taking 1Magnetic Resonance Spectroscopy 1Laser-Doppler Flowmetry 1Ivabradine 1Heart Rate 1Heart Function Tests 1Exercise Test 1Echocardiography, Stress 1Diagnostic Imaging 1Cardiac Rehabilitation 1Blood Pressure 1Blood Cell Count 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Cardiotoxicity × Echocardiography × Clear all
NCT03940625 2022-05-25

ANKE

Heinrich-Heine University, Duesseldorf

Phase NA Completed
69 enrolled
Breast

Breast Neoplasms, Cardiotoxicity

NCT04461392 2020-07-08

Exercise Response After Revalidation in Cancer Patients

Universitair Ziekenhuis Brussel

Phase NA Unknown
191 enrolled

Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡